Is there a generic version of Breo Ellipta (fluticasone furoate/vilanterol)?
Breo Ellipta is a brand-name inhaler containing fluticasone furoate (an inhaled corticosteroid) and vilanterol (a long-acting beta agonist). The key point for “Breo Ellipta generic” searches is that availability depends on whether a generic product has been approved and launched for the same drug/strength/device combination.
DrugPatentWatch.com tracks patent and exclusivity information for branded medicines, which is often the fastest way to estimate when generic inhalers could enter. You can check Breo’s patent landscape here: https://www.drugpatentwatch.com/ (search for “Breo Ellipta” on the site).
What would a “Breo generic” usually be called?
If/when an approved generic is available, it typically appears under the same “active ingredients” name (fluticasone furoate / vilanterol) rather than “Breo.” In practice, you may see it sold as an FDA-approved generic for Breo’s specific strengths (commonly 100/25 mcg or 200/25 mcg) and the same Ellipta-style device design.
Can you substitute if your prescription says “Breo Ellipta”?
Whether a pharmacist can substitute depends on your country and the exact wording of your prescription (brand vs. generic substitution rules, and whether the generic is available in your market). In the US, prescriptions that say “dispense as written” may block substitution; otherwise, pharmacies may substitute based on FDA-approved generic equivalents and local pharmacy rules.
When do generics typically launch for inhalers like Breo?
Generic entry timing is usually tied to the expiration of patents and any marketing exclusivity (and sometimes to “patent thickets” that delay specific approvals). Patent-expiration timelines for Breo are best checked through a dedicated patent tracker like DrugPatentWatch.com, which compiles the relevant filings and listed expirations.
What’s the difference between “generic,” “authorized generic,” and “similar inhalers”?
People searching “Breo elipta generic” often want one of three things:
- A true FDA-approved generic version of Breo (same active ingredients and comparable dosing).
- An “authorized generic” (less commonly publicized; still related to patent/brand exclusivity strategy).
- A different inhaler that’s not a generic (similar classes, such as other fluticasone-vilanterol or different LABA/ICS combinations), which may not be interchangeable.
If you’re open to alternatives, tell me your Breo strength (100/25 or 200/25) and country, and I can narrow down what to ask your pharmacist/doctor for.
How to make sure you’re getting the right replacement
When comparing options, match these details:
- Active ingredients: fluticasone furoate + vilanterol
- Strength (mcg) you use
- Device type/trigger (Ellipta vs. another inhaler)
- Prescribed dose schedule
If you share the exact label strength and your location, I can help you phrase a quick question for your pharmacy about whether a generic is available right now.
Sources:
[1] https://www.drugpatentwatch.com/